Stock listing

Lang & Schwarz:A118WG CareDx, Inc. Aktie

German listing (Lang & Schwarz) of CareDx, Inc. · home listing NASDAQ:CDNA

Follow CareDx, Inc. into a list and get an email when it puts out news.

Home listing price · NASDAQ:CDNA

$70.00 USD -4.44 (-6.0%)

Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:CDNA

Past year +344.2% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$69.26 – $72.81 USDNov 20, 2026
Volume
781,924 sharesNov 20, 2026
Market cap
$3.68B USDAt the close on Nov 20, 2026 · price × 52.54M shares outstanding
52-week range
$15.56 – $90.87 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$83.91M USDMedian day 1.18M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
CareDx, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:CDNA · Home$70.00 USD-4.44 (-6.0%)781,924$70.56$72.81$69.26$74.44Close on Nov 20, 2026
Frankfurt:1K9€63.50 EUR-4.50 (-6.6%)—€64.00€64.00€63.50€68.00Close on Nov 20, 2026
Stuttgart:1K9€63.50 EUR-2.00 (-3.1%)—€65.00€65.00€63.50€65.50Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:CDNA · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$70.00-4.44-6.0%$70.56$72.81$69.26781,924
$74.44-0.12-0.2%$74.81$75.58$72.32537,256
$74.56+0.84+1.1%$74.30$75.53$72.03813,950
$73.72-4.16-5.3%$77.28$78.36$73.311,030,751
$77.88-1.93-2.4%$78.51$80.00$76.67714,737
$79.81-1.36-1.7%$78.00$80.07$76.55685,550
$81.17+0.40+0.5%$82.00$84.10$80.18770,847
$80.77-3.65-4.3%$84.09$84.50$79.271,036,317
$84.42+5.86+7.5%$80.80$85.74$80.001,093,687
$78.56+2.23+2.9%$77.88$80.55$75.931,126,037
$76.33-9.53-11.1%$83.60$83.60$75.812,056,061
$85.86-2.61-3.0%$89.00$89.85$83.131,352,128
$88.47+2.59+3.0%$85.63$90.05$85.441,585,957
$85.88-1.53-1.8%$86.88$89.14$83.062,190,573
$87.41+15.89+22.2%$82.10$90.87$81.223,552,531
$71.52-0.61-0.8%$72.02$73.08$69.951,656,863
$72.13+1.60+2.3%$69.91$73.43$69.00905,915
$70.53+1.43+2.1%$69.10$72.48$68.601,175,449
$69.10-0.11-0.2%$68.87$70.31$68.33602,691
$69.21+0.05+0.1%$68.54$70.48$67.43746,068
$69.16-1.58-2.2%$69.65$71.51$66.84917,916
$70.74+1.54+2.2%$68.39$72.71$68.281,637,705
$69.20+2.12+3.2%$67.20$70.81$65.891,561,966
$67.08+3.08+4.8%$65.00$68.05$64.56990,719
$64.00-2.675-4.0%$66.34$68.09$62.851,497,600
$66.68+1.985+3.1%$63.72$68.17$62.211,302,500
$64.69-0.74-1.1%$64.40$67.73$63.341,191,400
$65.43+2.31+3.7%$62.57$67.39$62.231,497,800
$63.12-0.55-0.9%$63.28$64.47$61.34900,000
$63.67+1.465+2.4%$62.21$65.13$62.21895,600
$62.21-0.835-1.3%$61.89$63.45$61.191,571,200
$63.04-0.75-1.2%$61.38$65.10$61.381,700,600
$63.79-6.06-8.7%$70.89$72.51$63.742,561,100
$69.85+2.70+4.0%$66.89$70.75$66.171,636,300
$67.15+0.92+1.4%$66.33$69.80$65.881,588,100
$66.23+1.23+1.9%$64.96$67.29$64.151,910,800
$65.00+0.98+1.5%$63.87$65.63$63.121,768,100
$64.02-0.58-0.9%$64.74$65.50$62.90796,100
$64.60+0.92+1.4%$62.30$65.50$62.301,081,400
$63.68+2.31+3.8%$61.33$65.19$60.512,349,700
$61.37+7.06+13.0%$55.29$63.09$54.522,499,900
$54.31-2.18-3.9%$56.25$57.16$54.001,907,200
$56.49+2.16+4.0%$54.44$56.85$53.781,966,100
$54.33+0.50+0.9%$53.82$54.86$53.50766,700
$53.83-0.45-0.8%$53.97$54.46$53.121,384,000
$54.28+0.73+1.4%$54.00$55.16$53.21806,300
$53.55+0.91+1.7%$52.61$54.49$52.61846,100
$52.64+0.27+0.5%$52.20$53.74$51.73948,700
$52.37+2.11+4.2%$50.49$52.67$50.17795,200
$50.26+0.24+0.5%$50.14$50.85$49.57662,900
$50.02-0.010.0%$49.19$51.69$48.641,606,700
$50.03-0.28-0.6%$49.88$51.33$49.641,216,500
$50.31-0.57-1.1%$50.50$50.87$49.46935,100
$50.88+1.02+2.0%$49.65$50.99$48.681,307,200
$49.86+0.26+0.5%$49.75$50.50$48.39636,700
$49.60+0.63+1.3%$49.55$51.37$48.40825,700
$48.97-1.14-2.3%$49.93$50.62$48.251,247,800
$50.11+0.32+0.6%$49.16$50.28$46.691,533,700
$49.79-2.57-4.9%$51.50$52.38$49.601,178,100
$52.36+1.40+2.7%$51.00$53.67$50.771,250,900
$50.96+0.16+0.3%$50.15$51.08$49.071,415,300
$50.80+3.30+6.9%$48.13$51.13$47.231,787,935
$47.50-1.11-2.3%$48.30$48.51$46.92769,594
$48.61+1.62+3.4%$46.99$48.72$46.051,159,900
$46.99+0.48+1.0%$45.90$47.85$45.33911,200
Ticker
Lang & Schwarz:A118WG
Asset type
Stock
Sector
Health care
Industry
Diagnostics & research services
Exchange
Lang & Schwarz
Currency
EUR

What changed lately

Latest news

All CareDx, Inc. news

CareDx, Inc. on 6ix

Sector
Health care
Industry
Diagnostics & research services
News releases
32 in the last 12 months · 275 in all · newest Nov 20, 2026 · oldest 2019
Calls
27 calls with a replay · 27 with a transcript · latest Oct 29, 2026
Decks
25 decks · latest Oct 29, 2026

Where CareDx, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:CDNA · Home listingNASDAQUnited StatesUSD
gettex:1K9gettexGermanyEUR
LS Exchange:A118WGLS ExchangeGermanyEUR
Lang & Schwarz:A118WG · This pageLang & SchwarzGermanyEUR
BOATS:CDNABOATSUnited StatesUSD
Tradegate:1K9TradegateGermanyEUR
Dusseldorf:1K9DusseldorfGermanyEUR
Frankfurt:1K9FrankfurtGermanyEUR
Munich:1K9MunichGermanyEUR
Stuttgart:1K9StuttgartGermanyEUR

Valuation

P/E 28.6× against a median of 24.0×: 5th lowest of 7 Diagnostics & research services companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$3.43B USD
P/E
28.6×
EV/sales
6.9×
EV/EBITDA
No depreciation figure on 6ix yet
Price/book
7.9×
Gross margin
Not reported
Operating margin
23.4%
Net margin
25.9%
Debt to equity
0.0×
Beta vs S&P 500
1.26

Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
CareDx, Inc. · NASDAQ:CDNAUS$3.68BUS$3.43B28.6×6.9×n/a7.9×25.9%0.0×1.26
GRAIL, Inc. · NASDAQ:GRALUS$4.46BUS$3.76Bn/a22.6×n/a1.8×−243.8%0.0×2.83
SAI Life Sciences Ltd. · NSE:SAILIFEUS$4.13BUS$4.13B106×17.0×58.1×15.4×16.1%0.0×n/a
BillionToOne, Inc. · NASDAQ:BLLNUS$3.83BUS$3.36B77.6×7.7×59.6×6.8×11.3%0.2×1.35
Tecan Group AG · SIX:TECNUS$3.50BUS$3.49Bn/a3.3×34.0×2.6×−12.5%0.2×n/a
Piramal Pharma Limited · NSE:PPLPHARMAUS$3.42BUS$3.97Bn/a3.8×30.6×3.9×−2.1%0.7×n/a
Siegfried Holding AG · SIX:SFZNUS$3.40BUS$4.38B16.9×2.8×12.0×2.9×12.7%0.9×n/a
Apeloa Pharmaceutical Co. Ltd. Class A · SZSE:000739US$3.29BUS$2.84B27.3×2.1×n/a3.4×9.1%0.1×n/a
Autobio Diagnostics Co., Ltd. Class A · SSE:603658US$3.28BUS$3.05B20.8×4.7×n/a2.4×24.3%0.0×n/a
Joinn Laboratories (China) Co., Ltd. Class A · SSE:603127US$3.04BUS$2.66B17.7×9.6×n/a2.2×61.6%0.0×n/a
MGI Tech Co., Ltd. Class A · SSE:688114US$2.92BUS$2.53Bn/a5.5×n/a2.8×−9.5%0.2×n/a
Median of the othersUS$3.41BUS$3.43B24.0×5.1×34.0×2.8×10.2%0.1×2.09

Forecasts

5 strong buy · 1 buy · 2 hold · Analysts' consensus from EODHD, read Nov 17, 2026. Not 6ix's view and not investment advice.

Price target
94.43 USD · Analysts' mean
EPS, year to Dec 2026
1.78 · 7 analysts
Revenue, year to Dec 2026
524.8M · 8 analysts

Team and board

OfficerRole
John W. HannaPresident and Chief Executive Officer
Keith KennedyChief Financial Officer and Chief Operating Officer
Jeffrey A. NovackGeneral Counsel
Natasha Moshirian WagnerInvestor Relations
Jeffrey TeutebergChief Medical Officer
Jessica MengChief Commercial Officer
Jing HuangChief Data and AI Officer
Kashif RathoreChief Technology Officer
Marica GrskovicChief Strategy Officer
Robert N. WoodwardChief Scientific Officer

Events

Calls

CallWhenStatus
CareDx (NASDAQ:CDNA) Q3 2026 Earnings CallThu, Oct 29, 2026 · 4:30 PM ETReplay
CareDx (NASDAQ:CDNA) Q2 2026 Earnings CallThu, Jul 30, 2026 · 4:30 PM ETReplay
CareDx (NASDAQ:CDNA) Q1 2026 Earnings CallTue, Apr 28, 2026 · 4:30 PM ETReplay
CareDx (NASDAQ:CDNA) Q4 2025 Earnings CallTue, Feb 24, 2026 · 4:30 PM ETReplay
CareDx (NASDAQ:CDNA) Q3 2025 Earnings CallTue, Nov 04, 2025 · 4:30 PM ETReplay
CareDx (NASDAQ:CDNA) Q2 2025 Earnings CallWed, Aug 06, 2025 · 4:30 PM ETReplay
CareDx (NASDAQ:CDNA) Q1 2025 Earnings CallWed, Apr 30, 2025 · 4:30 PM ETReplay
CareDx (NASDAQ:CDNA) Q4 2024 Earnings CallWed, Feb 26, 2025 · 4:30 PM ETReplay
CareDx (NASDAQ:CDNA) Q3 2024 Earnings CallMon, Nov 04, 2024 · 4:30 PM ETReplay
CareDx (NASDAQ:CDNA) Q2 2024 Earnings CallWed, Jul 31, 2024 · 4:30 PM ETReplay
All 27 calls
CallWhenStatus
CareDx (NASDAQ:CDNA) Q1 2024 Earnings CallThu, May 09, 2024 · 4:30 PM ETReplay
CareDx (NASDAQ:CDNA) Q4 2023 Earnings CallWed, Feb 28, 2024 · 4:30 PM ETReplay
CareDx (NASDAQ:CDNA) Q3 2023 Earnings CallWed, Nov 08, 2023 · 4:30 PM ETReplay
CareDx (NASDAQ:CDNA) Q2 2023 Earnings CallTue, Aug 08, 2023 · 4:30 PM ETReplay
CareDx (NASDAQ:CDNA) Q1 2023 Earnings CallWed, May 10, 2023 · 4:30 PM ETReplay
CareDx (NASDAQ:CDNA) Q4 2022 Earnings CallMon, Feb 27, 2023 · 4:30 PM ETReplay
CareDx (NASDAQ:CDNA) Q3 2022 Earnings CallThu, Nov 03, 2022 · 4:30 PM ETReplay
CareDx (NASDAQ:CDNA) Q2 2022 Earnings CallThu, Aug 04, 2022 · 4:30 PM ETReplay
CareDx (NASDAQ:CDNA) Q1 2022 Earnings CallThu, May 05, 2022 · 4:30 PM ETReplay
CareDx (NASDAQ:CDNA) Q4 2021 Earnings CallThu, Feb 24, 2022 · 4:30 PM ETReplay
CareDx (NASDAQ:CDNA) Q3 2021 Earnings CallThu, Oct 28, 2021 · 4:30 PM ETReplay
CareDx (NASDAQ:CDNA) Q2 2021 Earnings CallThu, Jul 29, 2021 · 4:30 PM ETReplay
CareDx (NASDAQ:CDNA) Q1 2021 Earnings CallWed, May 05, 2021 · 4:30 PM ETReplay
CareDx (NASDAQ:CDNA) Q4 2020 Earnings CallWed, Feb 24, 2021 · 4:30 PM ETReplay
CareDx (NASDAQ:CDNA) Q3 2020 Earnings CallThu, Oct 29, 2020 · 4:30 PM ETReplay
CareDx (NASDAQ:CDNA) Q2 2020 Earnings CallThu, Aug 20, 2020 · 4:30 PM ETReplay
CareDx (NASDAQ:CDNA) Q1 2020 Earnings CallThu, Apr 30, 2020 · 4:30 PM ETReplay

Results days

QuarterResultsShare move
Q3 2026Oct 29, 2026 · After close+22.2%
Q2 2026Jul 30, 2026 · After close+14.7%
Q1 2026Apr 28, 2026 · After close−5.1%
Q4 2025Mar 4, 2026−0.3%
Q3 2025Nov 4, 2025 · After close+13.8%
Q2 2025Aug 6, 2025 · After close−7.9%
Q1 2025Apr 30, 2025 · After close−10.7%
Q4 2024Feb 26, 2025 · After close−0.2%
Q3 2024Nov 4, 2024 · After close−0.1%
Q2 2024Jul 31, 2024 · After close+18.0%
All 20 quarters
QuarterResultsShare move
Q1 2024May 9, 2024 · After close+34.1%
Q4 2023Feb 28, 2024 · After close+9.5%
Q3 2023Nov 8, 2023 · After close+13.9%
Q2 2023Aug 8, 2023 · After close−11.2%
Q1 2023May 10, 2023 · After close−2.7%
Q4 2022Feb 27, 2023 · After close+14.3%
Q3 2022Nov 3, 2022 · After close−14.5%
Q2 2022Aug 4, 2022 · After close+8.6%
Q1 2022May 5, 2022 · After close−18.6%
Q4 2021Feb 24, 2022 · After close−1.9%

Open Events

Decks

DeckKindSlidesDate
Q3 2026 Earnings PresentationEarnings28 slidesOct 29, 2026
Q2 2026 Earnings PresentationEarnings26 slidesJul 30, 2026
Q1 2026 Earnings PresentationEarnings37 slidesApr 28, 2026
Q4 2025 Earnings PresentationEarnings29 slidesFeb 24, 2026
Investor Presentation (February 2026)Investor deck35 slidesFeb 12, 2026
Q3 2025 Earnings PresentationEarnings24 slidesNov 4, 2025
Q2 2025 Earnings PresentationEarnings31 slidesAug 6, 2025
Jefferies Global Healthcare Conference 2025Conference25 slidesJun 5, 2025
Q1 2025 Earnings PresentationEarnings24 slidesApr 30, 2025
Q4 2024 Earnings PresentationEarnings19 slidesFeb 26, 2025
All 25 decks
DeckKindSlidesDate
43rd Annual J.P. Morgan Healthcare Conference (January 2025)Conference23 slidesJan 14, 2025
The 36th Annual Piper Sandler Healthcare Conference (December 2024)Conference23 slidesDec 4, 2024
Q3 2024 Earnings PresentationEarnings19 slidesNov 4, 2024
Investor Day (October 2024)Investor day60 slidesOct 15, 2024
Q2 2024 Earnings PresentationEarnings20 slidesJul 31, 2024
Q1 2024 Earnings PresentationEarnings16 slidesMay 9, 2024
Investor Presentation (January 2024)Investor deck42 slidesJan 9, 2024
Q4 2022 Earnings PresentationEarnings22 slidesFeb 27, 2023
Q4 2022 Earnings PresentationEarnings26 slidesFeb 27, 2023
Investor Presentation (January 2023)Investor deck28 slidesJan 9, 2023
Q3 2022 Earnings PresentationEarnings14 slidesNov 3, 2022
Q3 2022 Earnings PresentationEarnings18 slidesNov 3, 2022
Investor Presentation (February 2021)Investor deck24 slidesFebruary 2021
Q3 2019 Earnings PresentationEarnings28 slidesNovember 2019
Merger or Acquisition (April 2016)Merger or acquisition21 slidesApr 21, 2016

Open Decks

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue379.8M333.8M280.3M321.8M296.4M192.2M127.1M76.6M48.3M40.6M
Cost of revenue45.5M33.0M21.4M10.2M
Gross profit81.6M43.6M27.0M30.4M
Research and development71.4M72.5M82.4M90.4M76.5M48.9M30.7M14.5M12.4M12.4M
Operating income-30.8M40.8M-203.4M-77.2M-29.7M-22.5M-24.5M-15.6M-20.3M-37.3M
Depreciation and amortization15.0M14.2M14.4M11.6M8.80M7.01M5.52M4.21M3.73M2.92M
EBITDA-15.8M55.0M-189.0M-65.6M-20.9M-15.5M-19.0M-11.4M-16.6M-34.4M
Income before tax-21.1M52.9M-190.1M-76.2M-32.1M-19.8M-23.9M-48.2M-57.3M-41.4M
Income tax271.0K310.0K141.0K379.0K-1.43M-1.04M-1.98M-1.43M-1.71M-1.61M
Net income-21.4M52.5M-190.3M-76.6M-30.7M-18.7M-22.0M-46.8M-55.5M-39.5M
Earnings per share, basic-0.401.00-3.54-1.44-0.59-0.40-0.52-1.31-2.38-2.39
Earnings per share, diluted-0.400.93-3.54-1.44-0.59-0.40-0.52-1.31-2.38-2.39

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents65.4M114.7M82.2M89.9M348.5M134.7M38.2M64.6M16.9M17.3M
Short-term investments111.8M146.0M153.2M203.2M090.0M0
Receivables42.6M64.6M51.1M66.3M59.8M34.6M24.1M9.76M2.99M2.77M
Inventory26.7M19.5M19.5M19.2M17.2M10.0M6.01M4.94M5.53M5.46M
Current assets257.1M351.8M313.7M387.8M433.4M273.1M71.9M81.1M26.8M26.7M
Property, plant and equipment33.0M33.6M35.2M35.5M22.0M10.7M4.43M4.13M2.08M2.93M
Goodwill40.3M40.3M40.3M37.5M37.0M23.9M23.9M12.0M12.0M13.8M
Total assets413.2M491.1M466.8M543.0M566.6M368.5M151.7M130.7M83.6M76.7M
Accounts payable9.99M7.69M12.9M9.94M13.3M9.65M5.51M4.71M3.39M3.06M
Current liabilities89.8M89.4M78.1M76.0M77.3M69.2M34.8M19.5M42.9M40.8M
Long-term debt00018.3M1.10M
Total debt00034.1M23.9M
Total liabilities110.1M112.6M205.5M112.1M100.7M90.8M52.7M34.8M89.5M57.0M
Shareholders' equity303.1M378.4M261.3M430.9M465.9M277.7M99.0M95.9M-6.13M19.5M
Shares outstanding50.9M54.8M51.5M53.5M52.9M49.4M42.5M41.4M28.8M21.3M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations42.0M38.0M-18.4M-25.2M-19.3M33.4M-2.77M-4.01M-14.3M-16.5M
Capital spending-2.04M-186.0K-549.0K
Free cash flow-6.04M-14.5M-17.1M
Cash from investing2.16M-483.0K40.4M-228.5M47.7M-100.4M-22.6M-7.93M-6.11M-21.1M
Cash from financing-93.4M-5.61M-29.6M-4.54M185.6M163.1M-132.0K50.3M29.4M24.9M
Share buybacks-87.8M-522.0K-27.5M-642.0K00
Change in cash-49.3M32.5M-7.66M-258.3M213.8M96.5M-26.3M38.3M9.07M-12.6M

Open Financials

Filings

FilingDateTypeFiled with
4 · Change in ownershipNov 18, 2026Insider tradeSEC
4 · Change in ownershipNov 16, 2026Insider tradeSEC
4 · Change in ownershipNov 16, 2026Insider tradeSEC
144 · Notice of proposed saleNov 16, 2026Other filingsSEC
4 · Change in ownershipNov 12, 2026Insider tradeSEC
4 · Change in ownershipNov 12, 2026Insider tradeSEC
144 · Notice of proposed saleNov 12, 2026Other filingsSEC
144 · Notice of proposed saleNov 10, 2026Other filingsSEC
SCHEDULE 13G · Big-stake noticeNov 10, 2026Big-stake noticeSEC
4 · Change in ownershipNov 9, 2026Insider tradeSEC
Show 200 filings
FilingDateTypeFiled with
4 · Change in ownershipNov 9, 2026Insider tradeSEC
144 · Notice of proposed saleNov 5, 2026Other filingsSEC
4 · Change in ownershipNov 4, 2026Insider tradeSEC
4 · Change in ownershipNov 3, 2026Insider tradeSEC
10-Q · Quarterly reportOct 29, 2026Quarterly reportSEC
8-K · Current reportOct 29, 2026ResultsSEC
4 · Change in ownershipOct 5, 2026Insider tradeSEC
4 · Change in ownershipOct 5, 2026Insider tradeSEC
4 · Change in ownershipOct 5, 2026Insider tradeSEC
4 · Change in ownershipOct 5, 2026Insider tradeSEC
4 · Change in ownershipOct 5, 2026Insider tradeSEC
8-K/A · Current report, amendedSep 16, 2026Acquisition or disposalSEC
4 · Change in ownershipSep 15, 2026Insider tradeSEC
4 · Change in ownershipSep 15, 2026Insider tradeSEC
144 · Notice of proposed saleAug 17, 2026Other filingsSEC
144 · Notice of proposed saleAug 14, 2026Other filingsSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 14, 2026Big-stake noticeSEC
144 · Notice of proposed saleAug 13, 2026Other filingsSEC
144 · Notice of proposed saleAug 12, 2026Other filingsSEC
144 · Notice of proposed saleAug 11, 2026Other filingsSEC
144 · Notice of proposed saleAug 10, 2026Other filingsSEC
144 · Notice of proposed saleAug 10, 2026Other filingsSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 7, 2026Big-stake noticeSEC
144 · Notice of proposed saleAug 7, 2026Other filingsSEC
SCHEDULE 13G · Big-stake noticeAug 7, 2026Big-stake noticeSEC
4 · Change in ownershipAug 6, 2026Insider tradeSEC
4 · Change in ownershipAug 6, 2026Insider tradeSEC
4 · Change in ownershipAug 6, 2026Insider tradeSEC
4 · Change in ownershipAug 6, 2026Insider tradeSEC
144 · Notice of proposed saleAug 5, 2026Other filingsSEC
144 · Notice of proposed saleAug 5, 2026Other filingsSEC
144 · Notice of proposed saleAug 5, 2026Other filingsSEC
4 · Change in ownershipAug 4, 2026Insider tradeSEC
144 · Notice of proposed saleAug 4, 2026Other filingsSEC
144 · Notice of proposed saleAug 4, 2026Other filingsSEC
144 · Notice of proposed saleAug 4, 2026Other filingsSEC
144 · Notice of proposed saleAug 4, 2026Other filingsSEC
S-8 · Registration statement for employee plansJul 30, 2026Offer documentSEC
10-Q · Quarterly reportJul 30, 2026Quarterly reportSEC
8-K · Current reportJul 30, 2026ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedJul 27, 2026Big-stake noticeSEC
4 · Change in ownershipJul 17, 2026Insider tradeSEC
4 · Change in ownershipJul 17, 2026Insider tradeSEC
144 · Notice of proposed saleJul 16, 2026Other filingsSEC
144 · Notice of proposed saleJul 16, 2026Other filingsSEC
4 · Change in ownershipJul 7, 2026Insider tradeSEC
8-K · Current reportJul 7, 2026Acquisition or disposalSEC
4 · Change in ownershipJul 6, 2026Insider tradeSEC
4 · Change in ownershipJul 2, 2026Insider tradeSEC
4 · Change in ownershipJul 2, 2026Insider tradeSEC
4 · Change in ownershipJul 2, 2026Insider tradeSEC
4 · Change in ownershipJun 30, 2026Insider tradeSEC
144 · Notice of proposed saleJun 29, 2026Other filingsSEC
4 · Change in ownershipJun 17, 2026Insider tradeSEC
4 · Change in ownershipJun 16, 2026Insider tradeSEC
4 · Change in ownershipJun 16, 2026Insider tradeSEC
4 · Change in ownershipJun 16, 2026Insider tradeSEC
4 · Change in ownershipJun 16, 2026Insider tradeSEC
4 · Change in ownershipJun 16, 2026Insider tradeSEC
4 · Change in ownershipJun 16, 2026Insider tradeSEC
4 · Change in ownershipJun 16, 2026Insider tradeSEC
4 · Change in ownershipJun 15, 2026Insider tradeSEC
144 · Notice of proposed saleJun 15, 2026Other filingsSEC
8-K · Current reportJun 15, 2026Management or board changeSEC
144 · Notice of proposed saleJun 11, 2026Other filingsSEC
4 · Change in ownershipJun 9, 2026Insider tradeSEC
4 · Change in ownershipJun 8, 2026Insider tradeSEC
DEFA14A · Additional proxy materialJun 5, 2026Meeting noticeSEC
144 · Notice of proposed saleJun 4, 2026Other filingsSEC
4 · Change in ownershipMay 18, 2026Insider tradeSEC
144 · Notice of proposed saleMay 15, 2026Other filingsSEC
144 · Notice of proposed saleMay 14, 2026Other filingsSEC
4 · Change in ownershipMay 6, 2026Insider tradeSEC
144 · Notice of proposed saleMay 5, 2026Other filingsSEC
4 · Change in ownershipMay 4, 2026Insider tradeSEC
S-3ASR · Registration statementApr 28, 2026Offer documentSEC
10-Q · Quarterly reportApr 28, 2026Quarterly reportSEC
8-K · Current reportApr 28, 2026ResultsSEC
ARS · Annual report to shareholdersApr 27, 2026Annual reportSEC
DEFA14A · Additional proxy materialApr 27, 2026Meeting noticeSEC
DEF 14A · Proxy statementApr 27, 2026Meeting noticeSEC
8-K/A · Current report, amendedApr 23, 2026Management or board changeSEC
4 · Change in ownershipApr 22, 2026Insider tradeSEC
4 · Change in ownershipApr 20, 2026Insider tradeSEC
144 · Notice of proposed saleApr 16, 2026Other filingsSEC
4 · Change in ownershipApr 16, 2026Insider tradeSEC
8-K · Current reportApr 16, 2026ResultsSEC
4 · Change in ownershipApr 7, 2026Insider tradeSEC
4 · Change in ownershipApr 3, 2026Insider tradeSEC
4 · Change in ownershipApr 3, 2026Insider tradeSEC
4 · Change in ownershipApr 3, 2026Insider tradeSEC
4 · Change in ownershipApr 3, 2026Insider tradeSEC
4 · Change in ownershipApr 3, 2026Insider tradeSEC
4 · Change in ownershipApr 1, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMar 26, 2026Big-stake noticeSEC
8-K/A · Current report, amendedFeb 25, 2026ResultsSEC
10-K · Annual reportFeb 25, 2026Annual reportSEC
8-K · Current reportFeb 24, 2026ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 12, 2026Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeFeb 9, 2026Big-stake noticeSEC
4 · Change in ownershipFeb 4, 2026Insider tradeSEC
4 · Change in ownershipFeb 4, 2026Insider tradeSEC
4 · Change in ownershipFeb 4, 2026Insider tradeSEC
4 · Change in ownershipFeb 4, 2026Insider tradeSEC
4 · Change in ownershipFeb 4, 2026Insider tradeSEC
144 · Notice of proposed saleFeb 3, 2026Other filingsSEC
4 · Change in ownershipJan 23, 2026Insider tradeSEC
4 · Change in ownershipJan 20, 2026Insider tradeSEC
144 · Notice of proposed saleJan 15, 2026Other filingsSEC
8-K · Current reportJan 12, 2026ResultsSEC
4 · Change in ownershipJan 7, 2026Insider tradeSEC
8-K · Current reportDec 18, 2025Current reportSEC
8-K · Current reportDec 15, 2025Current reportSEC
4 · Change in ownershipDec 5, 2025Insider tradeSEC
144 · Notice of proposed saleDec 4, 2025Other filingsSEC
SCHEDULE 13G · Big-stake noticeNov 14, 2025Big-stake noticeSEC
4 · Change in ownershipNov 10, 2025Insider tradeSEC
4 · Change in ownershipNov 7, 2025Insider tradeSEC
144 · Notice of proposed saleNov 7, 2025Other filingsSEC
144 · Notice of proposed saleNov 5, 2025Other filingsSEC
S-8 · Registration statement for employee plansNov 4, 2025Offer documentSEC
10-Q · Quarterly reportNov 4, 2025Quarterly reportSEC
8-K · Current reportNov 4, 2025ResultsSEC
4 · Change in ownershipNov 4, 2025Insider tradeSEC
144 · Notice of proposed saleOct 31, 2025Other filingsSEC
SCHEDULE 13G/A · Big-stake notice, amendedOct 30, 2025Big-stake noticeSEC
4 · Change in ownershipOct 24, 2025Insider tradeSEC
3 · Initial statement of ownershipOct 24, 2025Insider tradeSEC
8-K · Current reportOct 24, 2025Management or board changeSEC
4 · Change in ownershipOct 7, 2025Insider tradeSEC
4 · Change in ownershipSep 15, 2025Insider tradeSEC
4 · Change in ownershipSep 15, 2025Insider tradeSEC
4 · Change in ownershipSep 12, 2025Insider tradeSEC
4 · Change in ownershipAug 11, 2025Insider tradeSEC
3 · Initial statement of ownershipAug 11, 2025Insider tradeSEC
4 · Change in ownershipAug 7, 2025Insider tradeSEC
10-Q · Quarterly reportAug 6, 2025Quarterly reportSEC
8-K · Current reportAug 6, 2025ResultsSEC
4 · Change in ownershipAug 5, 2025Insider tradeSEC
144 · Notice of proposed saleAug 5, 2025Other filingsSEC
4 · Change in ownershipAug 5, 2025Insider tradeSEC
SCHEDULE 13G · Big-stake noticeJul 24, 2025Big-stake noticeSEC
4 · Change in ownershipJul 14, 2025Insider tradeSEC
4 · Change in ownershipJul 10, 2025Insider tradeSEC
4 · Change in ownershipJul 8, 2025Insider tradeSEC
4 · Change in ownershipJun 23, 2025Insider tradeSEC
4 · Change in ownershipJun 20, 2025Insider tradeSEC
144 · Notice of proposed saleJun 18, 2025Other filingsSEC
4 · Change in ownershipJun 17, 2025Insider tradeSEC
4 · Change in ownershipJun 17, 2025Insider tradeSEC
4 · Change in ownershipJun 17, 2025Insider tradeSEC
4 · Change in ownershipJun 17, 2025Insider tradeSEC
4 · Change in ownershipJun 17, 2025Insider tradeSEC
4 · Change in ownershipJun 17, 2025Insider tradeSEC
4 · Change in ownershipJun 17, 2025Insider tradeSEC
4 · Change in ownershipJun 17, 2025Insider tradeSEC
4 · Change in ownershipJun 13, 2025Insider tradeSEC
8-K · Current reportJun 12, 2025Management or board changeSEC
144 · Notice of proposed saleJun 11, 2025Other filingsSEC
4 · Change in ownershipJun 10, 2025Insider tradeSEC
8-K · Current reportJun 3, 2025Current reportSEC
4 · Change in ownershipMay 30, 2025Insider tradeSEC
4 · Change in ownershipMay 29, 2025Insider tradeSEC
144 · Notice of proposed saleMay 28, 2025Other filingsSEC
4 · Change in ownershipMay 14, 2025Insider tradeSEC
144 · Notice of proposed saleMay 12, 2025Other filingsSEC
144 · Notice of proposed saleMay 12, 2025Other filingsSEC
4 · Change in ownershipMay 8, 2025Insider tradeSEC
4 · Change in ownershipMay 7, 2025Insider tradeSEC
144 · Notice of proposed saleMay 6, 2025Other filingsSEC
4 · Change in ownershipMay 5, 2025Insider tradeSEC
4 · Change in ownershipMay 5, 2025Insider tradeSEC
144 · Notice of proposed saleMay 5, 2025Other filingsSEC
4 · Change in ownershipMay 2, 2025Insider tradeSEC
144 · Notice of proposed saleApr 30, 2025Other filingsSEC
10-Q · Quarterly reportApr 30, 2025Quarterly reportSEC
8-K · Current reportApr 30, 2025ResultsSEC
ARS · Annual report to shareholdersApr 25, 2025Annual reportSEC
DEFA14A · Additional proxy materialApr 25, 2025Meeting noticeSEC
DEF 14A · Proxy statementApr 25, 2025Meeting noticeSEC
4 · Change in ownershipApr 23, 2025Insider tradeSEC
4 · Change in ownershipApr 17, 2025Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedApr 17, 2025Big-stake noticeSEC
4 · Change in ownershipApr 9, 2025Insider tradeSEC
4 · Change in ownershipApr 9, 2025Insider tradeSEC
4 · Change in ownershipApr 8, 2025Insider tradeSEC
8-K · Current reportMar 28, 2025Management or board changeSEC
4 · Change in ownershipMar 25, 2025Insider tradeSEC
4 · Change in ownershipMar 25, 2025Insider tradeSEC
4 · Change in ownershipMar 25, 2025Insider tradeSEC

This page holds 200 of 1,001 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from CareDx, Inc.’s releases · as of Nov 5, 2026

Common shares
52,542,786
Fully diluted
52,576,161

Fully diluted

LineSharesAs of
Common shares52,542,786Oct 26, 2026
Options and RSUs33,375Nov 5, 2026

Warrants and options

Lot
RSUs · expiry not stated

Share count over time

CountShares
Oct 26, 202652,542,786

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueAs of
BlackRock4.87M9.3%US$317MSep 30, 2026
Vanguard3.49M6.6%US$227MSep 30, 2026
State Street2.62M5.0%US$170MSep 30, 2026
Arrowstreet Capital, Limited Partnership2.06M3.9%US$134MSep 30, 2026
Blue Water Life Science Advisors, LP1.74M3.3%US$113MSep 30, 2026
ARK1.61M3.1%US$105MSep 30, 2026
Bamco Inc1.5M2.9%US$97.5MSep 30, 2026
Geode Capital1.48M2.8%US$96.3MSep 30, 2026
Divisadero Street Capital Management, LP1.42M2.7%US$92.3MSep 30, 2026
Chevy Chase Trust Holdings, LLC1.35M2.6%US$87.9MSep 30, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
D. E. Shaw & Co., Inc.1.28M2.4%US$83.4MSep 30, 2026
Renaissance Technologies1.26M2.4%US$81.6MSep 30, 2026
Dimensional1.18M2.2%US$76.5MSep 30, 2026
Citadel1.14M2.2%US$73.8MSep 30, 2026
Gagnon Securities LLC1.07M2.0%US$69.8MSep 30, 2026
Franklin Templeton986K1.9%US$84.6MSep 30, 2026
Orbimed Advisors LLC935K1.8%US$60.8MSep 30, 2026
Goldman Sachs932K1.8%US$60.6MSep 30, 2026
Driehaus Capital Management LLC709K1.3%US$46.1MSep 30, 2026
Qube Research & Technologies Ltd657K1.3%US$42.7MSep 30, 2026
Sumitomo Mitsui Trust Group, Inc.627K1.2%US$40.8MSep 30, 2026
Amova Asset Management Americas, Inc.625K1.2%US$40.6MSep 30, 2026
Ophir Asset Management Pty Ltd582K1.1%US$37.9MSep 30, 2026
Schwab519K0.99%US$33.8MSep 30, 2026
Nuveen517K0.98%US$33.6MSep 30, 2026
First Eagle Investment Management, LLC494K0.94%US$32.1MSep 30, 2026
Northern Trust471K0.90%US$30.6MSep 30, 2026
Royce & Associates LP468K0.89%US$30.4MSep 30, 2026
Bank of America454K0.86%US$29.5MSep 30, 2026
Morgan Stanley445K0.85%US$28.9MSep 30, 2026
Palo Alto Investors LP425K0.81%US$27.6MSep 30, 2026
Portolan Capital Management, LLC420K0.80%US$27.3MSep 30, 2026
Acadian Asset Management LLC407K0.78%US$26.5MSep 30, 2026
Oberweis Asset Management Inc/396K0.75%US$25.8MSep 30, 2026
Zweig-DiMenna Associates LLC390K0.74%US$25.3MSep 30, 2026
Fred Alger Management, LLC387K0.74%US$25.2MSep 30, 2026
Boston Partners381K0.73%US$24.8MSep 30, 2026
Susquehanna372K0.71%US$24.2MSep 30, 2026
Silvercrest Asset Management Group LLC363K0.69%US$23.6MSep 30, 2026
Lord, Abbett & Co. LLC351K0.67%US$22.8MSep 30, 2026
AQR Capital Management LLC345K0.66%US$22.4MSep 30, 2026
Russell Investments Group, Ltd.290K0.55%US$18.8MSep 30, 2026
Gagnon Advisors, LLC287K0.55%US$18.6MSep 30, 2026
Invesco271K0.52%US$17.6MSep 30, 2026
Fidelity260K0.49%US$16.9MSep 30, 2026
Millennium259K0.49%US$16.8MSep 30, 2026
Empowered Funds, LLC236K0.45%US$15.4MSep 30, 2026
Wellington205K0.39%US$13.3MSep 30, 2026
Parkman Healthcare Partners LLC200K0.38%US$13MSep 30, 2026
Citigroup Inc200K0.38%US$13MSep 30, 2026

This page holds 50 of 299 holders. Open Shareholders

Funds

HolderSharesOf the companyValueAs of
Vanguard Total Stock Market Index Fund1.55M3.0%US$44.3MJun 30, 2026
ARK Genomic Revolution ETF1.53M2.9%US$66.9MJul 31, 2026
Baron Discovery Fund1.37M2.6%US$39.1MJun 30, 2026
iShares Russell 2000 ETF1.34M2.6%US$38.2MJun 30, 2026
State Street(R) SPDR(R) S&P(R) Biotech ETF1.14M2.2%US$32.6MJun 30, 2026
Column Small Cap Select Fund652K1.2%US$14.9MMay 31, 2026
Vanguard Extended Market Index Fund588K1.1%US$16.8MJun 30, 2026
Fidelity Small Cap Index Fund561K1.1%US$24.5MJul 31, 2026
Strategic Advisers U.S. Total Stock Fund494K0.94%US$11.3MMay 31, 2026
First Eagle Small Cap Opportunity Fund485K0.92%US$21.2MJul 31, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
iShares Russell 2000 Growth ETF473K0.90%US$13.5MJun 30, 2026
iShares Biotechnology ETF329K0.63%US$9.38MJun 30, 2026
Invesco Biotechnology & Genome ETF325K0.62%US$14.2MJul 31, 2026
JNL Multi-Manager Small Cap Growth Fund289K0.55%US$8.25MJun 30, 2026
Fidelity Extended Market Index Fund267K0.51%US$6.08MMay 31, 2026
WPG Partners Select Small Cap Value Fund259K0.49%US$5.9MMay 31, 2026
Vanguard Russell 2000 Index Fund259K0.49%US$5.9MMay 31, 2026
Schwab U.S. Small-Cap ETF250K0.48%US$5.7MMay 31, 2026
Vanguard Strategic Equity Fund235K0.45%US$6.69MJun 30, 2026
Janus Henderson Small/Mid Cap Growth Alpha ETF230K0.44%US$10MJul 31, 2026
U.S. Small Cap Portfolio226K0.43%US$9.9MJul 31, 2026
Fidelity Enhanced Small Cap Core ETF217K0.41%US$6.17MJun 30, 2026
Meridian Small Cap Growth Fund187K0.36%US$5.33MJun 30, 2026
U.S. Micro Cap Portfolio182K0.35%US$7.93MJul 31, 2026
Dimensional U.S. Small Cap ETF173K0.33%US$7.55MJul 31, 2026
iShares Micro-Cap ETF172K0.33%US$4.9MJun 30, 2026
Vanguard Explorer Fund164K0.31%US$7.18MJul 31, 2026
Vanguard Health Care Index Fund152K0.29%US$3.47MMay 31, 2026
Burney U.S. Equity Select ETF141K0.27%US$4.02MJul 31, 2026
Dimensional U.S. Core Equity 2 ETF137K0.26%US$5.99MJul 31, 2026
Alger Small Cap Focus Fund135K0.26%US$5.9MJul 31, 2026
Schwab Small-Cap Index Fund125K0.24%US$5.45MJul 31, 2026
Royce Smaller-Companies Growth Fund119K0.23%US$3.39MJun 30, 2026
Royce Micro-Cap Fund111K0.21%US$3.17MJun 30, 2026
U.S. Small Cap Equity Fund105K0.20%US$4.6MJul 31, 2026
Fidelity Total Market Index Fund101K0.19%US$2.3MMay 31, 2026
Master Small Cap Index Series95,8760.18%US$2.73MJun 30, 2026
Avantis U.S. Small Cap Equity ETF92,2720.18%US$2.11MMay 31, 2026
Alger Small Cap Growth Fund90,9980.17%US$3.98MJul 31, 2026
Janus Henderson Small Cap Growth Alpha ETF88,5210.17%US$3.87MJul 31, 2026
Schwab Small-Cap Equity Fund86,3620.16%US$3.77MJul 31, 2026
Invesco RAFI US 1500 Small-Mid ETF80,9070.15%US$3.54MJul 31, 2026
Fidelity Series Total Market Index Fund78,2790.15%US$1.79MMay 31, 2026
U.S. Core Equity 2 Portfolio77,1940.15%US$3.37MJul 31, 2026
iShares Core S&P Total U.S. Stock Market ETF76,3130.15%US$2.17MJun 30, 2026
Goldman Sachs ActiveBeta(R) U.S. Small Cap Equity ETF73,8930.14%US$1.69MMay 31, 2026
State Street(R) SPDR(R) S&P Kensho New Economies Composite ETF71,8890.14%US$2.05MJun 30, 2026
Principal U.S. Small-Cap ETF70,1670.13%US$2MJun 30, 2026
Nuveen Small Cap Blend Index Fund67,9970.13%US$2.97MJul 31, 2026
iShares U.S. Small-Cap Equity Factor ETF59,9800.11%US$2.62MJul 31, 2026

This page holds 50 of 223 holders. Open Shareholders

Insider trades

TradeTradeSharesPriceValueDate
Riggsbee Richard Bryan
Director
Sale2,418USD 74.02US$179KNov 16, 2026
Riggsbee Richard Bryan
Director
Sale1,667USD 74.74US$125KNov 16, 2026
Riggsbee Richard Bryan
Director
Sale800USD 75.95US$60,761Nov 16, 2026
Riggsbee Richard Bryan
Director
Sale400USD 77.02US$30,809Nov 16, 2026
Goldberg Michael
Director
Sale3,547USD 78.32US$278KNov 12, 2026
Goldberg Michael
Director
Sale8,024USD 79.32US$636KNov 12, 2026
Goldberg Michael
Director
Sale2,229USD 79.85US$178KNov 12, 2026
Kennedy Keith
Officer: CFO & COO
Sale800USD 78.78US$63,026Nov 12, 2026
Kennedy Keith
Officer: CFO & COO
Sale1,297USD 79.61US$103KNov 12, 2026
Novack Jeffrey Adam
Officer: Secretary and General Counsel
Sale2,996USD 80.47US$241KNov 10, 2026
All 39 trades
TradeTradeSharesPriceValueDate
Novack Jeffrey Adam
Officer: Secretary and General Counsel
Sale200USD 81.05US$16,210Nov 10, 2026
Novack Jeffrey Adam
Officer: Secretary and General Counsel
Sale900USD 83.33US$74,995Nov 10, 2026
Kennedy Keith
Officer: CFO & COO
Sale28,256USD 76.55US$2.16MNov 5, 2026
Kennedy Keith
Officer: CFO & COO
Sale12,380USD 77.42US$958KNov 5, 2026
Kennedy Keith
Officer: CFO & COO
Sale6,897USD 78.59US$542KNov 5, 2026
Kennedy Keith
Officer: CFO & COO
Sale7,415USD 79.49US$589KNov 5, 2026
Kennedy Keith
Officer: CFO & COO
Sale3,403USD 80.38US$274KNov 5, 2026
Kennedy Keith
Officer: CFO & COO
Sale2,710USD 81.40US$221KNov 5, 2026
Kennedy Keith
Officer: CFO & COO
Sale300USD 82.08US$24,623Nov 5, 2026
Kennedy Keith
Officer: CFO & COO
Sale600USD 83.60US$50,160Nov 5, 2026
Bickerstaff George
Director
Sale20,000USD 46.29US$926KAug 5, 2026
Novack Jeffrey Adam
Officer: Secretary and General Counsel
Sale2,188USD 46.15US$101KAug 5, 2026
Novack Jeffrey Adam
Officer: Secretary and General Counsel
Sale500USD 46.75US$23,375Aug 5, 2026
Cournoyer Christine
Director
Sale16,000USD 46.94US$751KAug 4, 2026
Goldberg Michael
Director
Sale44,700USD 47.06US$2.1MAug 4, 2026
Hanna John Walter JR
Director, Officer: President and CEO
Sale50,000USD 36.11US$1.81MJul 16, 2026
Hanna John Walter JR
Director, Officer: President and CEO
Sale68,000USD 39.01US$2.65MJul 16, 2026
Valantine Hannah
Director
Sale28,679USD 36.14US$1.04MJul 16, 2026
Valantine Hannah
Director
Sale100USD 36.55US$3,655Jul 16, 2026
Hanna John Walter JR
Director, Officer: President and CEO
Sale39,900USD 29.24US$1.17MJun 29, 2026
Hanna John Walter JR
Director, Officer: President and CEO
Sale100USD 29.00US$2,900Jun 26, 2026
Hanna John Walter JR
Director, Officer: President and CEO
Sale17,683USD 24.03US$425KJun 15, 2026
Valantine Hannah
Director
Sale12,103USD 23.11US$280KJun 15, 2026
Hanna John Walter JR
Director, Officer: President and CEO
Sale21,998USD 24.02US$528KJun 11, 2026
Hanna John Walter JR
Director, Officer: President and CEO
Sale4,835USD 24.00US$116KJun 4, 2026
Torres Arthur A
Director
Sale6,484USD 19.89US$129KMay 15, 2026
Torres Arthur A
Director
Sale4,086USD 20.97US$85,683May 14, 2026
Novack Jeffrey Adam
Officer: Secretary and General Counsel
Sale2,688USD 20.68US$55,588May 5, 2026
Hanna John Walter JR
Director, Officer: President and CEO
Sale10,282USD 21.12US$217KApr 16, 2026

Big stakes

StakeStakeSharesDateFiling
BlackRock, Inc.9.00%4.66MJun 30, 2026Schedule 13G
State Street Corp5.10%2.62MSep 30, 2026Schedule 13G

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
George Bickerstaff
Other companies: Sio Gene Therapies Inc (Director · Feb 11, 2018 – Apr 15, 2019 · Past); Innoviva, Inc. (Director · Dec 19, 2017 – Apr 25, 2022 · Past); Inovio Pharmaceuticals, Inc. (Director · Mar 21, 2017 – Mar 21, 2018 · Past); Ariad Pharmaceuticals Inc (Director · May 4, 2016 – Feb 16, 2017 · Past); BMP Sunstone CORP (Director · Apr 28, 2008 – Apr 28, 2008 · Past); Vion Pharmaceuticals Inc (Director · Jun 28, 2006 – Dec 11, 2008 · Past)
Director · Since at least Jul 16, 2014
Brook H Byers
Other companies: Veracyte, Inc. (Director · Oct 29, 2013 – May 20, 2014 · Past); Foundation Medicine Inc (Director · Sep 24, 2013 – Apr 7, 2015 · Past); Pacific Biosciences of California, Inc. (Director · Oct 26, 2010 – May 17, 2016 · Past); Genomic Health Inc (Director · May 25, 2006 – Apr 1, 2011 · Past)
Director · Jul 16, 2014 – Apr 1, 2016 · Past
Douglas S Miller
Other companies: ChronoScale Corporation (Director · Since at least May 5, 2026); Applied Digital Corporation (Director · Since at least Apr 12, 2022); Procera Networks Inc (Director · May 30, 2013 – Jun 4, 2015 · Past); Telenav Inc (Director · May 12, 2010 – Feb 17, 2021 · Past)
Director · Jul 14, 2016 – Apr 1, 2017 · Past
Amy Abernethy
Other companies: EQRx Inc (Director · Dec 17, 2021 – Nov 9, 2023 · Past); CM Life Sciences III Inc. (Director · Aug 2, 2021 – Aug 2, 2021 · Past); athenahealth Inc (Director · Oct 22, 2013 – Jun 6, 2018 · Past)
Director · Jul 1, 2018 – Jan 22, 2019 · Past
Charles Constanti
Other companies: Procera Networks Inc (Chief Financial Officer · May 11, 2009 – Jun 4, 2015 · Past); Netopia Inc (VP, Chief Financial Officer · Jan 31, 2006 – Feb 6, 2007 · Past)
Chief Financial Officer · Apr 6, 2016 – Feb 17, 2017 · Past
Fred E Cohen
Other companies: Intellia Therapeutics, Inc. (Director · Since at least Jun 9, 2026); Kyverna Therapeutics, Inc. (Director · Since at least May 27, 2026)
Director · Since at least Jun 12, 2026
Hannah Valantine
Other companies: BridgeBio Pharma, Inc. (Director · Since at least Oct 23, 2021); Pacific Biosciences of California, Inc. (Director · Since at least Jun 16, 2021)
Director · Since at least Jul 1, 2021
Keith Kennedy
Other companies: Veracyte, Inc. (COO / CFO · Dec 6, 2016 – Mar 2, 2021 · Past); MCG Capital Corp (President and CEO, Director · Aug 14, 2015 – Aug 18, 2015 · Past)
Chief Financial Officer and Chief Operating Officer · Since at least Sep 12, 2024
Peter Maag
Other companies: Kyverna Therapeutics, Inc. (Chief Executive Officer, Director · Feb 7, 2024 – Feb 7, 2024 · Past); Miromatrix Medical Inc (Director · Jun 23, 2021 – Dec 12, 2023 · Past)
Director · Since at least Jul 16, 2014
Abhishek Jain
Other companies: NeoGenomics, Inc. (Chief Financial Officer · Since at least Jan 12, 2026)
Chief Financial Officer · Since at least May 26, 2022
All 33 people
PersonSeat
Christine M. Cournoyer
Other companies: Spok Holdings, Inc. (Chair of the Board · Since at least Apr 1, 2025)
Director · Since at least May 6, 2025
Joshua DeFonzo
Other companies: Lux Health Tech Acquisition Corp (Chief Executive Officer, Director · Oct 26, 2020 – Oct 26, 2020 · Past)
Chief Commercial Officer · Apr 1, 2015 – Jan 22, 2016 · Past
Michael Goldberg
Other companies: Genomic Health Inc (Director · Jun 13, 2007 – Aug 23, 2007 · Past)
Director · Since at least Mar 31, 2026
Reginald Seeto
Other companies: Ardelyx, Inc. (Chief Operating Officer · Oct 22, 2016 – Jan 16, 2018 · Past)
See Remarks, Director · Nov 26, 2018 – Oct 2, 2023 · Past
Richard Bryan Riggsbee
Other companies: Neogen Corporation (CFO · Since at least Aug 14, 2026)
Director · Since at least Jun 12, 2026
Abraham RonaiSee Remarks · Sep 7, 2022 – Sep 20, 2023 · Past
Alexander L JohnsonSee Remarks · Jul 19, 2021 – Aug 20, 2024 · Past
Arthur A TorresDirector · Since at least Sep 15, 2021
Jeffrey A. NovackGeneral Counsel · Since at least Apr 24, 2024
Jeffrey TeutebergChief Medical Officer · Since at least Nov 3, 2026
Jessica MengChief Commercial Officer · Since at least Nov 4, 2024
Jing HuangChief Data and AI Officer · Since at least Mar 5, 2026
John Walter Hanna JrPresident and CEO, Director · Since at least Apr 1, 2026
John W. HannaPresident and Chief Executive Officer · Since at least Oct 5, 2026
Kashif RathoreChief Technology Officer · Since at least Nov 5, 2026
Marica GrskovicChief Strategy Officer · Since at least Dec 11, 2024
Matthew J MeyerChief Business Officer · Jul 16, 2014 – Jan 22, 2016 · Past
Natasha Moshirian WagnerInvestor Relations · Since at least Jul 1, 2026
Nathan SmithChief Financial Officer · Since at least Aug 7, 2025
Robert N. WoodwardChief Scientific Officer · Since at least Oct 23, 2025
Sasha KingChief Marketing Officer · Oct 20, 2017 – Aug 9, 2022 · Past
Todd WhitsonChief Commercial Officer · Apr 18, 2016 – Feb 17, 2017 · Past
William A HagstromDirector · Since at least Jul 1, 2015

Open People

Log in to ask 6ix AI your own questions about CareDx, Inc.